The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity.

PLoS One 2013 16;8(4):e61916. Epub 2013 Apr 16.

Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland.

The Hippo (Hpo) pathway is a novel signaling pathway that controls organ size in Drosophila and mammals and is deregulated in a variety of human cancers. It consists of a set of kinases that, through a number of phosphorylation events, inactivate YAP, a transcriptional co-activator that controls cellular proliferation and apoptosis. We have identified PTPN14 as a YAP-binding protein that negatively regulates YAP activity by controlling its localization. Mechanistically, we find that the interaction of ectopic YAP with PTPN14 can be mediated by the respective WW and PPxY motifs. However, the PTPN14 PPxY motif and phosphatase activity appear to be dispensable for the negative regulation of endogenous YAP, likely suggesting more complex mechanisms of interaction and modulation. Finally, we demonstrate that PTPN14 downregulation can phenocopy YAP activation in mammary epithelial cells and synergize with YAP to induce oncogenic transformation.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0061916PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628344PMC
November 2013
36 Reads

Publication Analysis

Top Keywords

yap activity
8
yap
7
ptpn14
5
ptpn14 yap-binding
4
interaction modulation
4
apoptosis identified
4
modulation finally
4
identified ptpn14
4
yap-binding protein
4
regulates yap
4
complex mechanisms
4
negatively regulates
4
mechanisms interaction
4
protein negatively
4
proliferation apoptosis
4
finally demonstrate
4
ptpn14 downregulation
4
appear dispensable
4
events inactivate
4
phosphorylation events
4

Similar Publications